Google says its health AI is moving from research into clinical and public health use

The work now spans faster diagnosis, mammography screening, genomic analysis and disease risk mapping, with results Google says can shorten clinical and public health workflows.

Google says its health research work has reached a new level of practical impact, with models and tools being used for disease biology, diagnosis, and public health planning. The company cites a clinical trial with Stanford University School of Medicine where DeepVariant and DeepConsensus helped produce whole-genome diagnoses in under eight hours, a result it says earned a Guinness World Record. It also reports mammography research with Imperial College London and the NHS across 125,000 women that found 25% of historically missed interval cancers and could cut specialist reading workload by up to 40%. Beyond diagnostics, Google says AlphaGenome Atlas helped University of Exeter researchers analyze data from more than 54,000 people, and that its work with WHO AFRO and the DRC’s INRB sped up Ebola risk mapping by replacing weeks of manual coding. The broader message is that Google is packaging AI research into tools that can shorten lab and clinical workflows rather than just generate papers.